abs00916 Recombinant Human IFN-β1b
參考價(jià) | ¥ 720 |
訂貨量 | ≥1 |
具體成交價(jià)以合同協(xié)議為準(zhǔn)
- 公司名稱 愛必信(上海)生物科技有限公司
- 品牌 absin
- 型號(hào) abs00916
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時(shí)間 2025/7/28 19:30:50
- 訪問次數(shù) 1521
產(chǎn)品標(biāo)簽
聯(lián)系方式:愛必信18438616290 查看聯(lián)系方式
聯(lián)系我們時(shí)請(qǐng)說明是化工儀器網(wǎng)上看到的信息,謝謝!
供貨周期 | 一周 | 規(guī)格 | 2ug |
---|
概述 | |
---|---|
種屬 | Human |
形態(tài) | Lyophilized from a 0.2 µm filtered concentrated solution in PBS, pH 7.4, containing 2 % HSA and 3 % mannitol. |
來源 | Escherichia coli. |
氨基酸序列 | MSYNLLGFLQ RSSNFQCQKL LWQLNGRLEY CLKDRMNFDI PEEIKQLF QKEDAALTIY EMLQNIFAIF RQDSSSTGWN ETIVENLLAN VYHQINHLKT VLEEKLEKED FTRGKLMSSL HLKRYYGRIL HYLKAKEYSH CAWTIVRVEI LRNFYFINRL TGYLRN |
內(nèi)毒素水平 | Less than 1 EU/µg of Recombinant HumanIFN-β1b as determined by LAL method. |
活性 | Fully biologically active when compared to standard. The specific activity determined by an anti-viral assay is no less than 3.0 × 107 IU/mg. |
Accession # | P01574 |
預(yù)期分子量 | Approximay 20.0 kDa, a single non-glycosylated polypeptide chain containing 166 amino acids. |
性能 | |
---|---|
溶解方法 | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
保存方法 | This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles. |
純度 | > 97 % by SDS-PAGE and HPLC analyses. |
Gene IDs | 3456 |
參考文獻(xiàn) | |
---|---|
1. Yoshino A, Tashiro S, Ogino A, et al. 2011. Int J Oncol, 39: 529-42.<br/>2. Farrell RA, Marta M, Gaeguta AJ, et al. 2012. Rheumatology (Oxford), 51: 590-9.<br/>3. Breckpot K, Corthals J, Bonehill A, et al. 2005. J Leukoc Biol, 78: 898-908.<br/>4. Oger J, Francis G, Chang P. 2005. J Neurol Sci, 237: 45-52.<br/>5. Giorelli M, Livrea P, Trojano M. 2005. J Interferon Cytokine Res, 25: 395-406. |